Jay L. Patel, MD, MBA Vice President, PharmaDx and Clinical Trials Professor (Clinical), University of Utah School of MedicineSpecialties Molecular diagnosticsEducationMaster’s Degree—Business Administration, University of UtahMedical Degree—University of ArizonaResidency—Anatomic and Clinical Pathology, University of UtahFellowship—Hematopathology, Stanford UniversityCertification/AffiliationsAmerican Board of Pathology (Anatomic and Clinical Pathology, Hematology)Research InterestsApplication of next generation sequencing technologies in hematologic malignanciesRecent PublicationsKarner K, George TI, Patel JL. Current aspects of clonal hematopoiesis: implications for clinical diagnosis. Ann Lab Med. 2019;39(6):509-514.Szankasi P, Bolia A, Liew M, et al. Comprehensive detection of chromosomal translocations in lymphoproliferative disorders by massively parallel sequencing. J Hematopathol. 2019;12:121-133.Corean JLE, George TI, Patel JL, et al. Bone marrow findings in metastatic melanoma, including role of BRAF immunohistochemistry. Int J Lab Hematol. 2019;41(4):550-560.
Connect Sign In
